Encompass Health Corporation EHC
123.47
1.46
1.20%
as of 25 Sep
- Market cap
- $12.0B
- P/E
- 19.9×
Follow EHC
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 19.30% | 19.68% | 18.84% | 18.64% |
+8 more TTM periods Free account |
|
| 8.72% | 8.73% | 8.31% | 8.11% | ||
ROIC |
11.79% | 11.89% | 11.74% | 11.44% | |
Return on Tangible Assets |
13.77% | 13.94% | 13.57% | 13.40% | |
Average Days of Receivables |
40.42 | 40.67 | 38.08 | 38.47 | |
Free Cash Flow per Share |
4.18 | 4.68 | 4.37 | 4.01 | |
Free Cash Flow |
413.40 | 464.40 | 439.20 | 402.60 | |
Capital Expenditures |
(799.10) | (735.70) | (736.40) | (705.80) | |
Piotroski F-Score |
7.00 | 7.00 | 7.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
19.65% | 19.85% | 20.23% | 19.59% | |
Accounts Receivable Turnover |
9.55 | 9.34 | 9.75 | 9.76 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.20) | (0.21) | (0.20) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
60.09% | 60.50% | 60.76% | 61.19% | |
Share Based Compensation of Revenue |
0.93% | 0.96% | 0.95% | 0.87% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.95 | 1.97 | 2.08 | 2.05 | |
Depreciation/Fixed assets |
0.08 | 0.08 | 0.08 | 0.08 | |
Capex/Depreciation |
(2.24) | (2.13) | (2.18) | (2.14) | |
Revenue per Share |
62.81 | 61.15 | 59.06 | 57.67 | |
Operating CF per Share |
12.27 | 12.10 | 11.70 | 11.03 | |
Capex per Share |
(8.09) | (7.42) | (7.33) | (7.02) | |
Capex to Sales |
0.13 | 0.12 | 0.12 | 0.12 | |
Net Profit Margin |
10.01% | 10.04% | 9.54% | 9.33% |
Columns are period end dates